A detailed history of Kapitalo Investimentos Ltda transactions in Axonics, Inc. stock. As of the latest transaction made, Kapitalo Investimentos Ltda holds 323,432 shares of AXNX stock, worth $22.7 Million. This represents 5.49% of its overall portfolio holdings.

Number of Shares
323,432
Previous 335,427 3.58%
Holding current value
$22.7 Million
Previous $22.6 Billion 0.18%
% of portfolio
5.49%
Previous 6.76%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$67.3 - $69.67 $807,263 - $835,691
-11,995 Reduced 3.58%
323,432 $22.5 Billion
Q2 2024

Aug 14, 2024

SELL
$66.47 - $69.65 $1.18 Million - $1.24 Million
-17,754 Reduced 5.03%
335,427 $22.6 Billion
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $20 Million - $24.5 Million
353,181 New
353,181 $24.4 Billion

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.45B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Kapitalo Investimentos Ltda Portfolio

Follow Kapitalo Investimentos Ltda and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

News

Stay updated on Kapitalo Investimentos Ltda with notifications on news.